Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
Clinical trial NCT07392957 · RECRUITING
Trial details
- NCT number
- NCT07392957
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-16
- Primary completion
- 2029-06-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.